Bioventix PLC (BVXP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,650.00p

Buy

1,750.00p

arrow-down-25.00p (-1.45%)

Prices updated at 12 Dec 2025, 16:23 GMT

Prices minimum 15 mins delay

Prices in GBX

Bioventix PLC is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

26 Nov 2025

18 Nov 2025

11 Nov 2025

04 Nov 2025

30 Oct 2025

27 Oct 2025

28 Apr 2025

11 Apr 2025

31 Mar 2025

Key dates

	Forecast date
Annual general meeting	Dec 2026
Annual report	Nov 2026
Final results	Oct 2026
Half yearly results	Mar 2026

	Previous date
Annual general meeting	Dec 2025
Annual report	Nov 2025
Final results	Oct 2025
Half yearly results	Mar 2025

Company reports

30 Jun 2025

Annual Report

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.